Investor Relations Progenics Pharmaceuticals, Inc.

The Investor Relations website contains information about Progenics Pharmaceuticals, Inc.s business for stockholders, potential investors, and financial analysts.

OVERVIEW

This domain ir.progenics.com currently has an average traffic classification of zero (the smaller the higher page views). We have audited seventeen pages within the site ir.progenics.com and found ninety-two websites linking to ir.progenics.com. There are two mass networking platforms retained by this website.
Pages Analyzed
17
Links to this site
92
Social Links
2

IR.PROGENICS.COM RANKINGS

This domain ir.progenics.com has seen alternating amounts of traffic for the whole of the year.
Traffic for ir.progenics.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.progenics.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.progenics.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB PAGE

Progenics Pharmaceuticals Developing Innovative Cancer Therapies

Our mission as an oncology company is to develop innovative products that benefit cancer patients and their families. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video.

WHAT DOES IR.PROGENICS.COM LOOK LIKE?

Desktop Screenshot of ir.progenics.com Mobile Screenshot of ir.progenics.com Tablet Screenshot of ir.progenics.com

IR.PROGENICS.COM HOST

We detected that a single root page on ir.progenics.com took two hundred and sixty-eight milliseconds to stream. Our parsers could not detect a SSL certificate, so in conclusion our parsers consider this site not secure.
Load time
0.268 seconds
SSL
NOT SECURE
Internet Address
23.213.123.49

FAVORITE ICON

SERVER OPERATING SYSTEM

I discovered that this website is using the nginx os.

TITLE

Investor Relations Progenics Pharmaceuticals, Inc.

DESCRIPTION

The Investor Relations website contains information about Progenics Pharmaceuticals, Inc.s business for stockholders, potential investors, and financial analysts.

CONTENT

This domain ir.progenics.com has the following in the site, "PSMA Targeted Imaging Compound 1404 Technology." Our analyzers observed that the website also stated " 1133 PM EDT on Mar 29." The Website also stated " Progenics Investor relations Team works to provide, shareholders, analysts and potential investors with timely, relevant and reliable information. Progenics Pharmaceuticals Announces Three-Month Extension of PDUFA Date for AZEDRA iobenguane I 131."

MORE WEBSITES

Inżynieria Rolnicza

Author List by Place of Work.

PureDepth -

Stunning digital HMI with real depth. MLD featured as cover story for Elektronik Automotive magazine December 2017,. MLD Technology - BMW iVision Automotive CES 2016. PureDepth MLD is a unique premium display with real 3D depth. Two digital display layers with real depth. Advanced optical and software technology to deliver pure, safe 3D with stunning HMI optimized for depth. 5 Broadway, Auckland 1023,.

Relacje inwestorskie PZCORMAY

Zwołanie Zwyczajnego Walnego Zgromadzenia PZ CORMAY S. z siedzibą w Łomiankach na dzień 14 czerwca 2017 r. Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki. Projekty uchwał Zwyczajnego Walnego Zgromadzenia Spółki. Formularz pełnomocnictwa wraz z instrukcją do głosowania. Zwołanie Nadzwyczajnego Walnego Zgromadzenia PZ CORMAY S. na dzień 8 września 2016 r. Ogłoszenie o zwołaniu Nadzwyczajnego Walnego Zgromadzenia Spółki,.